The use of in vivo zebrafish assays in drug toxicity screening

By Eimon Peter M   Rubinstein Amy L  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 4, 2009-04 ,pp. : 393-401

Informa Healthcare

Access to resources Recommend Favorite

In vitro and in vivo models of drug ototoxicity: studying the mechanisms of a clinical problem

By Yorgason Joshua G   Luxford William   Kalinec Federico  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1521-1534

Informa Healthcare

Access to resources Recommend Favorite

Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models

By Sukardi Hendrian   Chng Hui Ting   Chan Eric Chun Yong   Gong Zhiyuan   Lam Siew Hong  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 5, 2011-05 ,pp. : 579-589

Informa Healthcare

Access to resources Recommend Favorite

In vivo models of cardiac diseases: application to drug development and screening

By Rokutan Hirofumi   Anker Stefan D   Springer Jochen  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 65-78

Informa Healthcare

Access to resources Recommend Favorite

In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery

By Darvesh Altaf S   Carroll Richard T   Geldenhuys Werner J   Gudelsky Gary A   Klein Jochen   Meshul Charles K   Van der Schyf Cornelis J  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 2, 2011-02 ,pp. : 109-127

Informa Healthcare

Access to resources Recommend Favorite